Literature DB >> 16249207

Are multiple sclerosis patients risk-takers?

C H Hawkes1.   

Abstract

Several factors appear to be associated with multiple sclerosis (MS), and each has a postulated immune or environmental explanation, but a common theme is lacking. This article suggests that a unifying premise could be risk-associated behaviour. Evidence is reviewed for associations with smoking, alcohol, recreational drug use, oral contraception, cholesterol intake, risk attitude and behaviour, ultraviolet light and vitamin D exposure, frequency of MS in healthy societies, and viral infection. The evidence associated with smoking, not taking vitamin D supplements and Epstein-Barr viral infection appears good. There may be a pattern of risk-associated behaviour that characterizes patients with MS and brings them into contact with one or more causative agents. Of the possible agents, viral infection seems the most likely.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249207     DOI: 10.1093/qjmed/hci135

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  10 in total

1.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

2.  Caffeine and alcohol intakes have no association with risk of multiple sclerosis.

Authors:  J Massa; E J O'Reilly; K L Munger; A Ascherio
Journal:  Mult Scler       Date:  2012-05-28       Impact factor: 6.312

3.  Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies.

Authors:  Tiantian Zhu; Xiaofei Ye; Tianyi Zhang; Zhiyong Lin; Wentao Shi; Xin Wei; Yuzhou Liu; Jia He
Journal:  Neurol Sci       Date:  2015-07-10       Impact factor: 3.307

4.  Predictors of risk tolerance among oral surgery patients.

Authors:  Kathryn A Atchison; Claudia Der-Martirosian; Thomas R Belin; Edward E Black; Melanie W Gironda
Journal:  J Oral Maxillofac Surg       Date:  2010-08-03       Impact factor: 1.895

Review 5.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

6.  Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study.

Authors:  Amirali Ghahremani; Sahar Mosa Farkhani; Mahsa Baniasadi; Seyed Kaveh Hojjat; Hasan Namdar Ahmadabad; Davoud Salarbashi; Sepideh Elyasi; Najmeh Davoodian
Journal:  Brain Behav       Date:  2022-04-22       Impact factor: 3.405

7.  Emotional change-associated T cell mobilization at the early stage of a mouse model of multiple sclerosis.

Authors:  Giuseppa Piras; Lorenza Rattazzi; Adam McDermott; Robert Deacon; Fulvio D'Acquisto
Journal:  Front Immunol       Date:  2013-11-21       Impact factor: 7.561

8.  Vitamin D machinery and metabolism in porcine adipose-derived mesenchymal stem cells.

Authors:  Yovani Llamas Valle; Sami G Almalki; Devendra K Agrawal
Journal:  Stem Cell Res Ther       Date:  2016-08-17       Impact factor: 6.832

9.  Relation between personality disorders and characteristics of multiple sclerosis patients and their parents.

Authors:  Mina Nazari Kamal; Rahele Samouei; Sheida Sarrafzadeh; Shima Tamannaeifar; Nafiseh Ghaebi; Reza Behrouzi
Journal:  J Educ Health Promot       Date:  2018-08-02

Review 10.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.